# Natural History Study in Patients With LGMDR5/2c

> **NCT06210672** · — · WITHDRAWN · sponsor: **Atamyo Therapeutics**

## Conditions studied

- Gamma-sarcoglycanopathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06210672
- **Lead sponsor:** Atamyo Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-01-10
- **Primary completion:** 2025-09-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of financing
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06210672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06210672, "Natural History Study in Patients With LGMDR5/2c". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06210672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*